3rdPartyFeeds News

Europe Markets: European stocks sluggish at start of short holiday week

European stocks remain muted as trading thinned ahead of the festive period Read More...

European equity markets struggled to build on record highs on Monday, as investors appeared to take a breather at the start of a holiday-shortened week.

The benchmark Stoxx 600 SXXP, +0.06%  traded flat at 418.57, after closing out Friday’s session with a 0.8% gain to 418.80, which marked a fresh closing high. The FTSE 100 UKX, +0.35% was unchanged at 7,586.74. Among other regional indexes, the German DAX 30 index DAX, -0.14%  was flat at 13,310.73 and the French CAC 40 index PX1, +0.04% was steady at 6,020.78. 

U.S. stock futures were trading flat after major indexes also closed out Friday’s trading at record highs, notching a fourth-straight week of gains, amid optimism over economic data and international trade deals. Wall Street will trade a shortened Christmas Eve session on Tuesday, and close on Wednesday.

Positive trade developments continued on Monday as Chinese media reported the government will cut tariffs on 850 products. Separately, Beijing said it would open its oil, telecom and power markets to private competitors, in a bid to boost a slowing economy.

Sterling GBPUSD, -0.2384%  remained steady having come off its highs in the aftermath of Prime Minister Boris Johnson’s solid election victory.

“Perhaps a little profit taking but also, of course, the additional of a legal end-date to the withdrawal bill, raising the risk of no-deal WTO [World Trade Organization] Brexit. Still, it’s just about hanging in there above 1.30 against the U.S. dollar,” Craig Erlam, senior market analyst at OANDA Europe, said in a note to clients.

Which stocks are active?

Banks made up the weakest sector, with shares of Commerzbank CBK, -0.81%  sliding 1.5%, and Société Générale GLE, -0.48%  and Credit Suisse Group CSGN, -1.02%  down 1% each.

Shares in German chemicals maker Bayer BAYN, +2.99%  rose almost 3% to €73.41 on the Frankfurt stock exchange, after the U.S. government said that a $25 million glyphosate decision against the company should be reversed. The Environmental Protection Agency, working with the Justice Department, filed court papers on Friday saying that the weedkiller’s active ingredient isn’t a carcinogen and, as a result, a warning on the label wasn’t required as California state law demands. Bayer denies its Roundup weedkiller causes cancer.

In the U.K., shares of FTSE 100 company NMC Health NMC, +30.76%  rose almost 20% after the U.A.E.-based health care group launched an independent review of its books. The company is looking to reassure investors after U.S. short seller Muddy Waters last week raised “serious doubts” about its finances, which wiped more than £2 billion off its market value.

Read More

Add Comment

Click here to post a comment